<DOC>
	<DOCNO>NCT00066456</DOCNO>
	<brief_summary>Phase I trial study effectiveness low-dose radiation therapy abdomen combine docetaxel treat patient recurrent persistent advanced ovarian , peritoneal , fallopian tube cancer . Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy , docetaxel , work different way stop tumor cell divide stop grow die . Combining chemotherapy radiation therapy may kill tumor cell .</brief_summary>
	<brief_title>Radiation Therapy Abdomen Plus Docetaxel Treating Patients With Recurrent Persistent Advanced Ovarian , Peritoneal , Fallopian Tube Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose docetaxel combination low-dose abdominal radiotherapy patient recurrent persistent advanced ovarian , peritoneal , fallopian tube cancer . II . Determine safety toxicity regimen patient . OUTLINE : This multicenter , dose-escalation study docetaxel . Patients receive docetaxel IV 30 minute daily day 1 , 8 , 15 , 22 , 29 , 35 . Within 3 hour begin docetaxel , patient also receive low-dose abdominal radiotherapy twice daily ( least 4 hour apart ) day 1 , 2 , 8 , 9 , 15 , 16 , 22 , 24 , 29 , 30 , 35 , 36 . Treatment continue absence unacceptable toxicity . Cohorts 3-6 patient receive escalate dos docetaxel maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose-limiting toxicity . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Diagnosis ovarian , peritoneal , fallopian tube carcinoma Radiographic , clinical , pathologic evidence relapse Recurrent persistent disease chemotherapy ( may enrol first subsequent relapse ) Received prior taxane OR platinum agent Performance status GOG 01 WBC least 3,000/mm^3 Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT/SGPT great 2.5 time ULN Alkaline phosphatase great 2.5 time ULN Creatinine great 1.5 time ULN Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No grade 2 great neuropathy ( sensory motor ) No septicemia No severe infection No circumstance would preclude study completion No prior radiotherapy abdomen pelvis Patients ureteral obstruction must undergo stent nephrostomy tube replacement prior study entry</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>